Item 8.01 Other Events
As previously disclosed in a proxy statement/prospectus dated December 16, 2022,
Health Sciences Acquisitions Corporation 2, a Cayman Islands exempted company
("HSAC2" or the "Company"), will hold an extraordinary general meeting of
shareholders (the "General Meeting") on January 24, 2023 for the purposes of
considering and voting upon, among other things, the previously announced
business combination of HSAC Olympus Merger Sub, Inc., a Delaware corporation
and a majority-owned subsidiary of HSAC2, with Orchestra BioMed, Inc., a
Delaware corporation (the "Business Combination").
The submission of the Business Combination to the shareholders entitles holders
of public shares in the Company to redeem their shares for their pro rata
portion of the funds held in the trust account established at the time of the
HSAC2 initial public offering. In connection with the General Meeting, as of
January 23, 2023, HSAC2 has received requests for redemption from shareholders
with respect to 1,597,888 HSAC2 ordinary shares.
1© Edgar Online, source Glimpses
HEAH SCIE 
